Invention Grant
- Patent Title: Antibodies that target HIV GP120 and methods of use
-
Application No.: US18365869Application Date: 2023-08-04
-
Publication No.: US11987617B2Publication Date: 2024-05-21
- Inventor: Mini Balakrishnan , Brian A. Carr , Magdeleine S. Hung , Manu Kanwar , Doug Rehder , Matthew Robert Schenauer , Loredana Serafini , Nathan D. Thomsen
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: GILEAD SCIENCES, INC.
- Current Assignee: GILEAD SCIENCES, INC.
- Current Assignee Address: US CA Foster City
- The original application number of the division: US16460094 2019.07.02
- Main IPC: A61K39/42
- IPC: A61K39/42 ; A61P31/18 ; C07K16/10 ; A61K45/06
Abstract:
Antibodies that bind to HIV gp120 and neutralize HIV are disclosed. Also disclosed are methods of using such antibodies alone or in combination with other therapeutic agents to treat or prevent HIV infection.
Public/Granted literature
- US20240034774A1 ANTIBODIES THAT TARGET HIV GP120 AND METHODS OF USE Public/Granted day:2024-02-01
Information query
